Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34.7M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+2.07M
-
Total reported value, excl. options
-
$463M
-
Value change
-
+$92.4M
-
Number of buys
-
37
-
Number of sells
-
-14
-
Price
-
$38.16
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q4 2019
60 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q4 2019.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 34.7M outstanding shares and own 35.12% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (3.14M shares), BAKER BROS. ADVISORS LP (3.14M shares), JANUS HENDERSON GROUP PLC (1.52M shares), RA CAPITAL MANAGEMENT, L.P. (983K shares), PRICE T ROWE ASSOCIATES INC /MD/ (918K shares), VANGUARD GROUP INC (505K shares), HILLHOUSE CAPITAL ADVISORS, LTD. (350K shares), BlackRock Inc. (333K shares), Cormorant Asset Management, LP (156K shares), and Artal Group S.A. (150K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.